Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Alzheimer's Disease

Free Subscription Articles published in Exp Neurol Retrieve available abstracts of 100 articles: HTML format

Single Articles

July 2026
1. GIANI A, Musi CA, Priori EC, Turchetti S, et al
   Revealing subcellular retinal alterations in 5xFAD B6SJLF1/J mice.
   Exp Neurol. 2026;401:115758.
   PubMed     Abstract available
   
   
   
2. XUE C, Chen C, Zou X, Li S, et al
   Hippocampal astrocyte St6galnac5 silencing improves spatial memory and preserves synaptic integrity in an AD mouse model.
   Exp Neurol. 2026;401:115742.
   PubMed     Abstract available
   
   
   
3. OUK K, Fernandez-Klett F, Schormann E, Greiner A, et al
   Rapamycin treatment reduces CD11c(+) microglia and increases amyloid plaque load in 5xFAD mice.
   Exp Neurol. 2026;401:115709.
   PubMed     Abstract available
   
   
   
4. WANG Y, Gao Q, Shang Z, Li X, et al
   Sulforaphane improved cognitive behavior in APP/PS1 mice via promoting structural and functional synaptic plasticity in the hippocampus.
   Exp Neurol. 2026;401:115727.
   PubMed     Abstract available
   
   
   May 2026
5. MARTINEZ-DRUDIS L, Sheta R, Musiol D, Teixeira M, et al
   The emerging role of polo-like kinase 2 in Alzheimer's disease.
   Exp Neurol. 2026;403:115806.
   PubMed     Abstract available
   
   
   
6. KHATTAB NA, El Kadeem A, Goda AE, El-Mahdy NA, et al
   Aluminum chloride in Alzheimer's disease: A dual focus on molecular mechanisms and rat experimental models.
   Exp Neurol. 2026;403:115814.
   PubMed     Abstract available
   
   
   
7. DELONCLE R
   Conjecture for a free radical epimerization process in Alzheimer, Parkinson, Lewy body, amyotrophic lateral sclerosis, progressive Supranuclear Palsy and Creutzfeldt Jakob diseases.
   Exp Neurol. 2026 May 5:115812. doi: 10.1016/j.expneurol.2026.115812.
   PubMed     Abstract available
   
   
   April 2026
8. GAO Q, Sun J, Hei B, Zhou J, et al
   Vitamin E and melatonin synergistically attenuate sleep deprivation-induced Nrf2 dysregulation and hippocampal ferroptosis in Alzheimer's disease mouse models.
   Exp Neurol. 2026;402:115781.
   PubMed     Abstract available
   
   
   
9. KAUR A, Singh S, Singh M, Silakari P, et al
   Corrigendum to "Demethyleneberberine attenuates combined cognitive and metabolic dysfunctions in an insulin-resistance-induced Alzheimer's disease rat model: Synthesis, in-silico and in-vivo insights" [Experimental Neurology, 398 (2026) 115634].
   Exp Neurol. 2026 Apr 23:115774. doi: 10.1016/j.expneurol.2026.115774.
   PubMed    
   
   
   
10. SHI L, Yang J, Guo Y, Wei B, et al
    TRPV1-tau axis: A bidirectional regulatory mechanism linking pain sensitization and Alzheimer's disease progression and its potential for intervention.
    Exp Neurol. 2026 Apr 19:115780. doi: 10.1016/j.expneurol.2026.115780.
    PubMed     Abstract available
    
    
    
11. CHEN L, Ye Y, Guo X, Li R, et al
    High-intensity interval training and moderate-intensity continuous training improve hippocampal synaptic plasticity in Alzheimer's disease via differential lactylation.
    Exp Neurol. 2026 Apr 16:115782. doi: 10.1016/j.expneurol.2026.115782.
    PubMed     Abstract available
    
    
    
12. ZHANG SZ, Ma Y, Ding Y, Yin YQ, et al
    Astrocytic TPK1 mitigates amyloid pathology via TFEB-mediated endocytosis.
    Exp Neurol. 2026;398:115640.
    PubMed     Abstract available
    
    
    March 2026
13. CHEN W, Huang N, Huang W, Wang M, et al
    TREM2 as a possible link between Alzheimer's disease and diabetes mellitus.
    Exp Neurol. 2026 Mar 18:115739. doi: 10.1016/j.expneurol.2026.115739.
    PubMed     Abstract available
    
    
    
14. ZHAO Y, Chen W, Zhou F
    IL-1beta neutralization ameliorates cognitive deficits and tau pathology in a mouse model of Alzheimer's disease with hyperhomocysteinemia.
    Exp Neurol. 2026;401:115729.
    PubMed     Abstract available
    
    
    
15. ZHU X, Lai X, Deng J, Long Y, et al
    Naturally occurring antibodies against ASC reduced in Alzheimer's disease and alleviating AD-type pathology in APP/PS1 mouse.
    Exp Neurol. 2026 Mar 15:115728. doi: 10.1016/j.expneurol.2026.115728.
    PubMed     Abstract available
    
    
    
16. LI W, Chen S, Liu Z, Lei B, et al
    Differential effects and underlying mechanisms of voluntary, forced, and combined exercise on ameliorating Alzheimer's disease pathophenotypes.
    Exp Neurol. 2026;401:115731.
    PubMed     Abstract available
    
    
    
17. KELLER M, Gallagher C, Marengo L, Bickenbach K, et al
    Meprin beta elevates hippocampal soluble Abeta in the APP/V717I mouse model.
    Exp Neurol. 2026;397:115600.
    PubMed     Abstract available
    
    
    February 2026
18. LI J, Sun W, Guo S, Bai J, et al
    The role of IGF1 signaling in remote ischemic conditioning-mediated amelioration of Alzheimer's disease pathology and cerebral insulin resistance.
    Exp Neurol. 2026 Feb 18:115685. doi: 10.1016/j.expneurol.2026.115685.
    PubMed     Abstract available
    
    
    
19. WU L, Hou F, Wang Z, Wu M, et al
    Mitochondrial calcium uniporter knockdown in hippocampal neurons effectively attenuates synaptic plasticity impairment and pathology in APP/PS1/tau model of Alzheimer's disease.
    Exp Neurol. 2026 Feb 11:115686. doi: 10.1016/j.expneurol.2026.115686.
    PubMed     Abstract available
    
    
    
20. FARKAS S, Jasper V, Nyers-Marosi K, Petrovai B, et al
    Targeting cholinergic cells in a mouse model of Alzheimer's disease: Validating a quadruple transgenic model.
    Exp Neurol. 2026;400:115684.
    PubMed     Abstract available
    
    
    January 2026
21. VAN ROOIJ JRA, van den Berg M, Van Vosselen M, Calus E, et al
    Long-term dietary interventions fail to mitigate functional connectivity loss and cognitive decline in the TgF344-AD rat model of Alzheimer's disease.
    Exp Neurol. 2026 Jan 14:115647. doi: 10.1016/j.expneurol.2026.115647.
    PubMed     Abstract available
    
    
    December 2025
22. CHEN X, Yao H, Ma S, Zhu H, et al
    FGF22/FGFR2/YAP modulates ferroptosis to suppress neurodegeneration and cognitive impairment in Alzheimer's disease.
    Exp Neurol. 2025 Dec 31:115630. doi: 10.1016/j.expneurol.2025.115630.
    PubMed     Abstract available
    
    
    
23. KAUR A, Singh S, Singh M, Silakari P, et al
    Demethyleneberberine attenuates combined cognitive and metabolic dysfunctions in an insulin-resistance-induced Alzheimer's disease rat model: Synthesis, in-silico and in-vivo insights.
    Exp Neurol. 2025 Dec 31:115634. doi: 10.1016/j.expneurol.2025.115634.
    PubMed     Abstract available
    
    
    
24. HEGNET E, Hakli S, Koivisto H, Miettinen PO, et al
    Age and sex dependent hippocampal neuronal hyperactivity in Alzheimer model mice.
    Exp Neurol. 2025 Dec 31:115632. doi: 10.1016/j.expneurol.2025.115632.
    PubMed     Abstract available
    
    
    
25. FU J, Ding C, Li W, Lei J, et al
    ELAVL1 interacts with APP and promotes Abeta-induced apoptosis in Alzheimer's disease by activating Bcl-2/Bax signaling.
    Exp Neurol. 2025;398:115613.
    PubMed     Abstract available
    
    
    
26. SUPASAI S, Suntaratti P, Odton M, Longji T, et al
    HMGB1 Box A gene therapy reverses cognitive and neuropathological features in AlCl(3)/D-galactose rat model of Alzheimer's disease.
    Exp Neurol. 2025 Dec 8:115583. doi: 10.1016/j.expneurol.2025.115583.
    PubMed     Abstract available
    
    
    
27. PAN JZ, Yu MY, Tian MZ, Liu R, et al
    Calcaratarin D exerts neuroprotective effects in Alzheimer's disease mouse model by inhibiting CERT-mediated NF-kappaB pathway.
    Exp Neurol. 2025;397:115585.
    PubMed     Abstract available
    
    
    November 2025
28. OKECHUKWU NG, Zaccone C, La Barbera L, Nobili A, et al
    Excitation-inhibition imbalance as a common thread linking early Alzheimer's disease with temporal lobe epilepsy.
    Exp Neurol. 2025 Nov 29:115581. doi: 10.1016/j.expneurol.2025.115581.
    PubMed     Abstract available
    
    
    
29. ALTINDAG F, Bayir MH, Alhalboosi JKI, Yildizhan K, et al
    Syringic acid mitigates scopolamine-induced cognitive impairment by regulating PSD-95 and GSK-3beta and by preventing neurodegeneration in an Alzheimer-like rat model.
    Exp Neurol. 2025 Nov 17:115556. doi: 10.1016/j.expneurol.2025.115556.
    PubMed     Abstract available
    
    
    
30. HEATH AM, Mojabi FS, Kraybill EP, Beard C, et al
    Comparison of treatment schedules on cognitive effects of rTMS in the 3xTg-AD model of Alzheimer's disease.
    Exp Neurol. 2025;396:115551.
    PubMed     Abstract available
    
    
    
31. YAO M, Li Z, Lin Y, Cai H, et al
    Hyperbaric oxygen therapy ameliorates Alzheimer's disease pathology by restoration of mitophagy and suppressing neuroinflammation in 5xFAD mice.
    Exp Neurol. 2025 Nov 4:115534. doi: 10.1016/j.expneurol.2025.115534.
    PubMed     Abstract available
    
    
    October 2025
32. ZHENG M, Zhang Q, Siebert HC, Loers G, et al
    Semaglutide attenuates Alzheimer's disease model progression by targeting microglial NLRP3 inflammasome-mediated neuroinflammation and ferroptosis.
    Exp Neurol. 2025 Oct 29:115537. doi: 10.1016/j.expneurol.2025.115537.
    PubMed     Abstract available
    
    
    
33. YOUSEFI A, Karimani F, Delphi L, Ghahfarokhi MR, et al
    Modulation of the mediodorsal thalamus nitric oxide system ameliorated amnesia and medial prefrontal abnormal network activity in a streptozotocin-induced rat model of Alzheimer's disease.
    Exp Neurol. 2025 Oct 22:115524. doi: 10.1016/j.expneurol.2025.115524.
    PubMed     Abstract available
    
    
    
34. VRBJAR N, Radosinska D, Radosinska J
    The involvement of Na,K-ATPase enzyme in the development of Alzheimer's disease.
    Exp Neurol. 2025 Oct 21:115526. doi: 10.1016/j.expneurol.2025.115526.
    PubMed     Abstract available
    
    
    
35. KIM D, Shim K, Kim J, Ko G, et al
    Potential anti-amyloid beta oligomerization effects of PD166793 in Alzheimer's disease.
    Exp Neurol. 2025 Oct 13:115504. doi: 10.1016/j.expneurol.2025.115504.
    PubMed     Abstract available
    
    
    
36. PANTIYA P, Chattipakorn N, Chattipakorn SC
    Exploring the role of CD147 in cerebrovascular and Alzheimer's pathologies: Insights into mechanisms and interventions.
    Exp Neurol. 2025;395:115498.
    PubMed     Abstract available
    
    
    
37. GENG D, Yan Y, Liu A, Zheng W, et al
    Experimental and computational study of 40?Hz low-field magnetic stimulation modulating neural activity and pathology in a mouse model of Alzheimer's disease.
    Exp Neurol. 2025 Oct 6:115494. doi: 10.1016/j.expneurol.2025.115494.
    PubMed     Abstract available
    
    
    
38. ZHANG M, Hai S, Gao X, Cui Z, et al
    MYT1L promotes autophagy to ameliorate amyloid-beta pathology and cognitive deficits in Alzheimer's disease via Notch signaling pathway.
    Exp Neurol. 2025 Oct 6:115492. doi: 10.1016/j.expneurol.2025.115492.
    PubMed     Abstract available
    
    
    
39. LI S, Zheng F, Liu S, Wu R, et al
    Physical exercise protects neurons from energy deficit and improves cognitive function by upregulating astrocytic Slc2a1 in Alzheimer's disease.
    Exp Neurol. 2025 Oct 6:115493. doi: 10.1016/j.expneurol.2025.115493.
    PubMed     Abstract available
    
    
    
40. CHEN G, Zhang J, Dong A, Xiao L, et al
    AXL-mediate GEF-H1 phosphorylation was involved in microglia synapse phagocytosis in 5xFAD mice.
    Exp Neurol. 2025;392:115327.
    PubMed     Abstract available
    
    
    September 2025
41. ONO K, Noguchi-Shinohara M, Yoshita M, Naiki H, et al
    Retraction Notice to "Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances -synuclein fibril formation in vitro" [Experimental Neurology 203 (2007) 579-583].
    Exp Neurol. 2025 Sep 10:115456. doi: 10.1016/j.expneurol.2025.115456.
    PubMed    
    
    
    August 2025
42. SU WS, Wu MT, Cheng IH, Yang FY, et al
    Low-intensity pulsed ultrasound enhances microglial-mediated Abeta clearance and synaptic preservation in an APP transgenic mouse model of Alzheimer's disease.
    Exp Neurol. 2025 Aug 12:115420. doi: 10.1016/j.expneurol.2025.115420.
    PubMed     Abstract available
    
    
    
43. KAYE S, Gold A, Lin D, Chen M, et al
    Hypercholesterolemia drives microglial dysfunction and weakens response to amyloid plaques.
    Exp Neurol. 2025;390:115272.
    PubMed     Abstract available
    
    
    July 2025
44. AZMAL M, Paul JK, Prima FS, Haque ANMSNB, et al
    Microglial dysfunction in Alzheimer's disease: Mechanisms, emerging therapies, and future directions.
    Exp Neurol. 2025;392:115374.
    PubMed     Abstract available
    
    
    
45. ALVES RL, Goncalves A, Voytyuk I, Harrison DC, et al
    Behaviour profile characterization of PS19 and rTg4510 tauopathy mouse models: A systematic review and a meta-analysis.
    Exp Neurol. 2025;389:115234.
    PubMed     Abstract available
    
    
    June 2025
46. FRENCH AR, Christian-Hinman CA
    Aromatase inhibition modulates intrinsic properties and excitability of hippocampal CA1 pyramidal cells in the APP/PS1 mouse model of Alzheimer's disease.
    Exp Neurol. 2025 Jun 30:115365. doi: 10.1016/j.expneurol.2025.115365.
    PubMed     Abstract available
    
    
    
47. HUNG WC, Sun WC, Su TC, Lee YJ, et al
    FGFR1 agonists alleviate pathology and cognitive impairment in an Alzheimer's disease mouse model.
    Exp Neurol. 2025 Jun 23:115357. doi: 10.1016/j.expneurol.2025.115357.
    PubMed     Abstract available
    
    
    
48. PENG XQ, Guo HS, Zhang X, Wu XY, et al
    TREM2 promotes hippocampal neurogenesis through regulating microglial M2 polarization in APP/PS1 mice.
    Exp Neurol. 2025;388:115205.
    PubMed     Abstract available
    
    
    May 2025
49. VIJAYAN V, Siddique IA, Gupta S, Chopra EM, et al
    Osteocalcin modulates Abeta42 aggregation to aid in amyloid reduction in mouse models of Alzheimer's disease.
    Exp Neurol. 2025 May 27:115322. doi: 10.1016/j.expneurol.2025.115322.
    PubMed     Abstract available
    
    
    
50. HE Q, Jiang L, Chao FL, Zhou CN, et al
    The role of LINGO-1 in regulating CB1R/TrkB signalling and GABAergic interneurons in Alzheimer's disease pathogenesis.
    Exp Neurol. 2025 May 27:115319. doi: 10.1016/j.expneurol.2025.115319.
    PubMed     Abstract available
    
    
    April 2025
51. SIM AY, Kim JY, Lee YH, Lee JE, et al
    Neuroprotective roles of SGLT2 and DPP4 inhibitors: Modulating ketone metabolism and suppressing NLRP3 inflammasome in T2D induced Alzheimer's disease.
    Exp Neurol. 2025 Apr 26:115271. doi: 10.1016/j.expneurol.2025.115271.
    PubMed     Abstract available
    
    
    
52. KERR NA, Bramlett HM, Sanchez-Molano J, Higueras AF, et al
    Stool-derived extracellular vesicles increase inflammasome signaling and regulate the gut-brain axis after stroke in Alzheimer's disease transgenic mice.
    Exp Neurol. 2025;390:115269.
    PubMed     Abstract available
    
    
    
53. REN J, Wang Y, Wang Y, Zhang Y, et al
    Dynamic changes of hippocampal dendritic spines in Alzheimer's disease mice among the different stages.
    Exp Neurol. 2025 Apr 15:115266. doi: 10.1016/j.expneurol.2025.115266.
    PubMed     Abstract available
    
    
    
54. ROZEBOOM A, Broekaart DWM, Anink JJ, Boonkamp L, et al
    Cellular expression of low-density lipoprotein receptor-related protein 1 and amyloid beta deposition in human and rat epileptogenic brain.
    Exp Neurol. 2025;386:115149.
    PubMed     Abstract available
    
    
    March 2025
55. LIU TT, Yang X, Lei HP, Hu YT, et al
    Gastrodin alleviates Abeta(25-35)-induced glycolytic dysfunction via activating PI3K/AKT/BACH1 signaling in Alzheimer's disease models.
    Exp Neurol. 2025 Mar 22:115225. doi: 10.1016/j.expneurol.2025.115225.
    PubMed     Abstract available
    
    
    
56. ALTUN S, Ozdemir S, Arslan H, Kiliclioglu M, et al
    Impact of long-term deltamethrin exposure on Alzheimer's-related neurodegeneration in rats.
    Exp Neurol. 2025;388:115223.
    PubMed     Abstract available
    
    
    
57. WANG A, Zhang F, Zhang W, Gong J, et al
    PPM1D ameliorates Alzheimer's disease by promoting mitophagy.
    Exp Neurol. 2025 Mar 14:115218. doi: 10.1016/j.expneurol.2025.115218.
    PubMed     Abstract available
    
    
    
58. DA SILVA EA, Faber J, Penitente AR, Fernandes J, et al
    Effects of resistance exercise on behavioral and molecular changes in transgenic female mice for Alzheimer's disease in early and advanced stages.
    Exp Neurol. 2025;388:115217.
    PubMed     Abstract available
    
    
    February 2025
59. CARTER SKR, Tipton RK, Forman CM, Mosher AP, et al
    Glutamate stress in the caudal nucleus tractus solitarii (nTS): Impact on respiratory function and synaptic signaling in an Alzheimer's disease model.
    Exp Neurol. 2025;387:115190.
    PubMed     Abstract available
    
    
    
60. RODRIGUEZ-LOPEZ A, Esteban D, Dominguez-Romero AN, Gevorkian G, et al
    Tg-SwDI transgenic mice: A suitable model for Alzheimer's disease and cerebral amyloid angiopathy basic research and preclinical studies.
    Exp Neurol. 2025;387:115189.
    PubMed     Abstract available
    
    
    January 2025
61. YANG MX, Wang ZR, Zhang YL, Zhang ZN, et al
    Albumin antagonizes Alzheimer's disease-related Tau pathology and enhances cognitive performance by inhibiting aberrant Tau aggregation.
    Exp Neurol. 2025 Jan 19:115155. doi: 10.1016/j.expneurol.2025.115155.
    PubMed     Abstract available
    
    
    
62. LIU S, Liu X, Ke M, Wang J, et al
    Sleep fragmentation impairs cognitive function and exacerbates Alzheimer's disease-related pathology in a mouse model by disrupting mitochondrial biogenesis.
    Exp Neurol. 2025;386:115153.
    PubMed     Abstract available
    
    
    
63. LI M, Mo Y, Yu Q, Anayyat U, et al
    Rotating magnetic field improves cognitive and memory impairments in APP/PS1 mice by activating autophagy and inhibiting the PI3K/AKT/mTOR signaling pathway.
    Exp Neurol. 2025;383:115029.
    PubMed     Abstract available
    
    
    December 2024
64. KAUR R, Pandey S, Gupta S, Singh J, et al
    Harnessing the potential of long non-coding RNAs in the pathophysiology of Alzheimer's disease.
    Exp Neurol. 2024;385:115134.
    PubMed     Abstract available
    
    
    
65. FRANKLIN Z, Hull C, Delibegovic M, Platt B, et al
    Pharmacological PTP1B inhibition rescues motor learning, neuroinflammation, and hyperglycaemia in a mouse model of Alzheimer's disease.
    Exp Neurol. 2024;385:115115.
    PubMed     Abstract available
    
    
    November 2024
66. WANG Y, Wu W, Zeng F, Meng X, et al
    The role of kynurenine pathway metabolism mediated by exercise in the microbial-gut-brain axis in Alzheimer's disease.
    Exp Neurol. 2024;384:115070.
    PubMed     Abstract available
    
    
    
67. EL-DESOUKY S, Abdel-Halim M, Fathalla RK, Abadi AH, et al
    A novel phosphodiesterase 5 inhibitor, RF26, improves memory impairment and ameliorates tau aggregation and neuroinflammation in the P301S tauopathy mouse model of Alzheimer's disease.
    Exp Neurol. 2024;384:115058.
    PubMed     Abstract available
    
    
    
68. MERINO-SERRAIS P, Soria JM, Arrabal CA, Ortigado-Lopez A, et al
    Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer's disease.
    Exp Neurol. 2024 Nov 8:115049. doi: 10.1016/j.expneurol.2024.115049.
    PubMed     Abstract available
    
    
    October 2024
69. DHIMAN N, Deshwal S, Rishi V, Singhal N, et al
    Zebrafish as a model organism to study sporadic Alzheimer's disease: Behavioural, biochemical and histological validation.
    Exp Neurol. 2024 Oct 25:115034. doi: 10.1016/j.expneurol.2024.115034.
    PubMed     Abstract available
    
    
    
70. ZHENG F, Dong T, Chen Y, Wang L, et al
    Border-associated macrophages: From physiology to therapeutic targets in Alzheimer's disease.
    Exp Neurol. 2024;383:115021.
    PubMed     Abstract available
    
    
    
71. WANG X, Wang Q, Wang X, Zhao H, et al
    Early intervention using long-term rhythmic pulsed magnetic stimulation alleviates cognitive decline in a 5xFAD mouse model of Alzheimer's disease.
    Exp Neurol. 2024 Oct 15:115002. doi: 10.1016/j.expneurol.2024.115002.
    PubMed     Abstract available
    
    
    September 2024
72. BALE LK, West SA, Gades NM, Baker DJ, et al
    Gene deletion of Pregnancy-associated Plasma Protein-A (PAPP-A) improves pathology and cognition in an Alzheimer's disease mouse model.
    Exp Neurol. 2024;382:114976.
    PubMed     Abstract available
    
    
    August 2024
73. YE Y, Fu C, Li Y, Sun J, et al
    Alternate-day fasting improves cognitive and brain energy deficits by promoting ketone metabolism in the 3xTg mouse model of Alzheimer's disease.
    Exp Neurol. 2024 Aug 12:114920. doi: 10.1016/j.expneurol.2024.114920.
    PubMed     Abstract available
    
    
    July 2024
74. BERETTI F, Gatti M, Ricchi F, Lipani F, et al
    Neurotoxic effects of coronavirus: Potential implications in Alzheimer's onset and progression.
    Exp Neurol. 2024 Jul 30:114908. doi: 10.1016/j.expneurol.2024.114908.
    PubMed     Abstract available
    
    
    
75. ZHAO Y, He C, Hu S, Ni H, et al
    Anti-oxidative stress and cognitive improvement of a semi-synthetic isoorientin-based GSK-3beta inhibitor in rat pheochromocytoma cell PC12 and scopolamine-induced AD model mice via AKT/GSK-3beta/Nrf2 pathway.
    Exp Neurol. 2024 Jul 10:114881. doi: 10.1016/j.expneurol.2024.114881.
    PubMed     Abstract available
    
    
    
76. LI CL, Zhou GF, Xie XY, Wang L, et al
    STAU1 exhibits a dual function by promoting amyloidogenesis and tau phosphorylation in cultured cells.
    Exp Neurol. 2024;377:114805.
    PubMed     Abstract available
    
    
    May 2024
77. HUANG XY, Xue LL, Ma RF, Shi JS, et al
    Inhibition of CXCR4: A perspective on miracle fruit seed for Alzheimer's disease treatment.
    Exp Neurol. 2024 May 29:114841. doi: 10.1016/j.expneurol.2024.114841.
    PubMed     Abstract available
    
    
    
78. EL-ARABY RE, Wasif K, Johnson R, Tu Q, et al
    Establishment of a novel cellular model for Alzheimer's disease in vitro studies.
    Exp Neurol. 2024 May 22:114820. doi: 10.1016/j.expneurol.2024.114820.
    PubMed     Abstract available
    
    
    
79. ZHANG Y, Mu BR, Ran Z, Zhu T, et al
    Pericytes in Alzheimer's disease: Key players and therapeutic targets.
    Exp Neurol. 2024 May 20:114825. doi: 10.1016/j.expneurol.2024.114825.
    PubMed     Abstract available
    
    
    
80. BARATI N, Shojaeian A, Ramezani M, Kalhori F, et al
    Investigating the effect of parasites (toxoplasma gondii RH strain, Leishmania major (MRHO/IR/75/ER), and hydatid cyst) antigens on Alzheimer's disease: An in vivo evaluation.
    Exp Neurol. 2024;377:114813.
    PubMed     Abstract available
    
    
    March 2024
81. ZHUGE F, Zheng L, Pan Y, Ni L, et al
    DPP-4 inhibition by linagliptin ameliorates age-related mild cognitive impairment by regulating microglia polarization in mice.
    Exp Neurol. 2024;373:114689.
    PubMed     Abstract available
    
    
    
82. ZUO Y, Liu HT, Lin LB, Yue RZ, et al
    A new metal ion chelator attenuates human tau accumulation-induced neurodegeneration and memory deficits in mice.
    Exp Neurol. 2024;373:114657.
    PubMed     Abstract available
    
    
    February 2024
83. ESHANI M, Anupam R, Raj SA, Ashish J, et al
    To evaluate the effect of endothelin receptor agonist IRL-1620 alone and in combination with donepezil in modulating neurodegeneration elicited by amyloid-beta in rats.
    Exp Neurol. 2024 Feb 9:114720. doi: 10.1016/j.expneurol.2024.114720.
    PubMed     Abstract available
    
    
    January 2024
84. XU M, Li J, Xia L, Du Y, et al
    PCSK6 exacerbates Alzheimer's disease pathogenesis by promoting MT5-MMP maturation.
    Exp Neurol. 2024 Jan 10:114688. doi: 10.1016/j.expneurol.2024.114688.
    PubMed     Abstract available
    
    
    
85. YUBOLPHAN R, Pratchayasakul W, Koonrungsesomboon N, Chattipakorn N, et al
    Potential links between platelets and amyloid-beta in the pathogenesis of Alzheimer's disease: Evidence from in vitro, in vivo, and clinical studies.
    Exp Neurol. 2024 Jan 9:114683. doi: 10.1016/j.expneurol.2024.114683.
    PubMed     Abstract available
    
    
    
86. DEMBY T, Gross PS, Mandelblatt J, Huang JK, et al
    The chemotherapeutic agent doxorubicin induces brain senescence, with modulation by APOE genotype.
    Exp Neurol. 2024;371:114609.
    PubMed     Abstract available
    
    
    November 2023
87. ISLA AG, Balleza-Tapia H, Chu F, Chen G, et al
    Low dose of levetiracetam counteracts amyloid beta-induced alterations of hippocampal gamma oscillations by restoring fast-spiking interneuron activity.
    Exp Neurol. 2023;369:114545.
    PubMed     Abstract available
    
    
    September 2023
88. HOSSEININIA M, Rostami F, Delphi L, Ghasemzadeh Z, et al
    Memory impairment was ameliorated by corticolimbic microinjections of arachidonylcyclopropylamide (ACPA) and miRNA-regulated lentiviral particles in a streptozotocin-induced Alzheimer's rat model.
    Exp Neurol. 2023 Sep 30:114560. doi: 10.1016/j.expneurol.2023.114560.
    PubMed     Abstract available
    
    
    
89. UPADHYAY P, Gupta S
    Dual mode of Triphala in the reversal of cognition through gut restoration in antibiotic mediated prolonged dysbiosis condition in 5XFAD mice.
    Exp Neurol. 2023;367:114473.
    PubMed     Abstract available
    
    
    August 2023
90. TIAN S, Ye T, Cheng X
    The behavioral, pathological and therapeutic features of the triple transgenic Alzheimer's disease (3 x Tg-AD) mouse model strain.
    Exp Neurol. 2023 Aug 17:114505. doi: 10.1016/j.expneurol.2023.114505.
    PubMed     Abstract available
    
    
    
91. HOSSAIN SR, Karem H, Jafari Z, Kolb BE, et al
    Early tactile stimulation influences the development of Alzheimer's disease in gestationally stressed APP (NL-G-F) adult offspring (NL-G-F/NL-G-F) mice.
    Exp Neurol. 2023 Aug 1:114498. doi: 10.1016/j.expneurol.2023.114498.
    PubMed     Abstract available
    
    
    June 2023
92. DU K, Dou Y, Chen K, Zhao Y, et al
    Activation of TRPV4 induces intraneuronal tau hyperphosphorylation via cholesterol accumulation.
    Exp Neurol. 2023;364:114392.
    PubMed     Abstract available
    
    
    May 2023
93. GHASEMI A, Qaffaripour Z, Tourani M, Saleki K, et al
    The relationship between long non-coding RNAs and Wnt/beta-catenin signaling pathway in the pathogenesis of Alzheimer's disease.
    Exp Neurol. 2023 May 16:114434. doi: 10.1016/j.expneurol.2023.114434.
    PubMed     Abstract available
    
    
    
94. WANG YY, Zhou YN, Jiang L, Wang S, et al
    Long-term voluntary exercise inhibited AGE/RAGE and microglial activation and reduced the loss of dendritic spines in the hippocampi of APP/PS1 transgenic mice.
    Exp Neurol. 2023;363:114371.
    PubMed     Abstract available
    
    
    April 2023
95. JAFARI Z, Afrashteh N, Kolb BE, Mohajerani MH, et al
    Hearing loss and impaired short-term memory in an Alzheimer's disease mouse model of amyloid-beta pathology.
    Exp Neurol. 2023 Apr 17:114413. doi: 10.1016/j.expneurol.2023.114413.
    PubMed     Abstract available
    
    
    
96. YANG YY, Ren YT, Jia MY, Bai CY, et al
    The human islet amyloid polypeptide reduces hippocampal tauopathy and behavioral impairments in P301S mice without inducing neurotoxicity or seeding amyloid aggregation.
    Exp Neurol. 2023;362:114346.
    PubMed     Abstract available
    
    
    
97. WU SL, Yu B, Cheng YJ, Ren SY, et al
    Brain region-specific myelinogenesis is not directly linked to amyloid-beta in APP/PS1 transgenic mice.
    Exp Neurol. 2023;362:114344.
    PubMed     Abstract available
    
    
    
98. LI L, Miao J, Jiang Y, Dai CL, et al
    Passive immunization inhibits tau phosphorylation and improves recognition learning and memory in 3xTg-AD mice.
    Exp Neurol. 2023;362:114337.
    PubMed     Abstract available
    
    
    March 2023
99. MEI Y, Li Y, Cheng YX, Gao L, et al
    The effect of gastric bypass surgery on cognitive function of Alzheimer's disease and the role of GLP1-SGLT1 pathway.
    Exp Neurol. 2023 Mar 7:114377. doi: 10.1016/j.expneurol.2023.114377.
    PubMed     Abstract available
    
    
    
100. WANG C, Chang Y, Zhu J, Wu Y, et al
     AdipoRon mitigates tau pathology and restores mitochondrial dynamics via AMPK-related pathway in a mouse model of Alzheimer's disease.
     Exp Neurol. 2023;363:114355.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum